Supplementary Data 2 from Molecular Profiling of Tisotumab Vedotin–Treated Patients Identifies Immune Pathways Associated with Clinical Activity
Authors:
- Sriram SridharSSSriram Sridhar
- M. Guy RoukensMRM. Guy Roukens
- Christina Y. YuCYChristina Y. Yu
- Tim DielenTDTim Dielen
- Berris van Kessel-WelmersBKBerris van Kessel-Welmers
- Han SiHSHan Si
- Steven XuSXSteven Xu
- Lauren K. BradyLBLauren K. Brady
- Merzu BeleteMBMerzu Belete
- Mark BiedaMBMark Bieda
- Khyati N. ShahKSKhyati N. Shah
- Regina AquinoRARegina Aquino
Open Access
- 1 October 2026
- other
- Published by American Association for Cancer Research (AACR)